Managing Director & Partner
Clemens Möller is a core member of the Health Care, People & Organization, and Public Sector practices at Boston Consulting Group. He leads the firm's work in biopharma R&D globally, and is the firm’s leading global expert in biomedical 3-D printing.
Clemens's work has focused on leading large-scale transformation initiatives with private and public sector clients. He has consulted biopharma companies and government health care agencies on strategy, innovation, operational readiness, process improvement, and organizational change. Clemens also has extensive experience utilizing data, analytics, and digital technology to drive business acceleration and sustainable value.
Before joining BCG in 2008, Clemens worked on identifying antiviral drug targets at Pfizer and investigated chronic kidney disease at Massachusetts General Hospital and Harvard Medical School.
The old innovation model at the big agricultural-input companies no longer works. To survive, they must go digital and focus on customer needs.
Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
As the deadline approaches and many details remain unclear, companies are left with no choice but to plan for a hard Brexit in March 2019. Here’s how to get ready.
Embracing digital innovation—especially for traditional companies—requires new capabilities, new ways of working, and a transformational mindset.